Muscle-invasive Bladder Cancer Radiation Therapy Guideline

microbiota systematic review urinary bladder neoplasms

Cohort Studies Humans *Hypertension *Metabolic Syndrome/epidemiology Obesity Risk Factors *Urinary Bladder Neoplasms/epidemiology Meta analysis Metabolic syndrome Metabolic syndrome components Urinary bladder neoplasm this study.

铥激光 经尿道等离子电切 非肌层浸润性膀胱癌 Meta分析

Apoptosis B7-H1 Antigen/genetics/metabolism *Carcinoma Transitional Cell/pathology Cystectomy Humans Immune Checkpoint Inhibitors Ligands Lymph Node Excision Neoplasm Recurrence Local/pathology Prognosis Programmed Cell Death 1 Receptor Urinary Bladder *Urinary Bladder Neoplasms/pathology bladder urothelial carcinoma meta-analysis prognostic value programmed cell death ligand-1 radical cystectomy commercial or financial relationships that could be construed as a potential conflict of interest.

蓝激光 膀胱肿瘤手术 操作规范 安全共识

*Cystoscopy Follow-Up Studies Humans Neoplasm Invasiveness Neoplasm Recurrence Local Prospective Studies *Urinary Bladder Neoplasms/diagnosis/therapy Nmibc Non-muscle invasive bladder cancer cystoscopy follow-up

三联保膀胱 膀胱根治术 肌层浸润性膀胱癌 放化疗 膀胱保存

Cystectomy/methods *Enhanced Recovery After Surgery Humans Length of Stay Meta-Analysis as Topic Postoperative Complications/surgery *Urinary Bladder Neoplasms/surgery

Cystoscopy/*methods Feasibility Studies Humans Liquid Biopsy/methods Sensitivity and Specificity *Spectrum Analysis Raman Urinary Bladder/diagnostic imaging/*pathology Urinary Bladder Neoplasms/*diagnosis/pathology/urine Urine/cytology Bladder cancer Raman spectroscopy diagnosis meta-analysis optical

高级别非肌层浸润性膀胱癌 根治性膀胱切除术 保留膀胱术 meta分析 临床疗效

Carcinoma Transitional Cell/*diagnostic imaging/*pathology Humans *Multiparametric Magnetic Resonance Imaging Neoplasm Staging/methods Reproducibility of Results Sensitivity and Specificity Urinary Bladder Neoplasms/*diagnostic imaging/*pathology

Antineoplastic Agents Alkylating/pharmacology/*therapeutic use Cyclophosphamide/pharmacology/*therapeutic use Female Humans Male Survival Analysis Urinary Bladder Neoplasms/*drug therapy/mortality Cyclophosphamide Hematuria Systematic review Urinary bladder neoplasms

Antineoplastic Agents/*therapeutic use Chemotherapy Adjuvant/*statistics & numerical data *Cystectomy Global Health Guideline Adherence/statistics & numerical data Humans Models Statistical Neoadjuvant Therapy/*statistics & numerical data Neoplasm Invasiveness Practice Guidelines as Topic Practice Patterns Physicians'/*statistics & numerical data Urinary Bladder Neoplasms/*drug therapy/pathology/surgery

Cystectomy/*methods Humans Neoplasm Invasiveness Urethra Urinary Bladder Neoplasms/pathology/*surgery Bladder tumor En bloc resection Meta-analysis Transurethral resection

Blood Loss Surgical/statistics & numerical data Cystectomy/*methods Humans Length of Stay/statistics & numerical data Lymph Node Excision *Minimally Invasive Surgical Procedures Operative Time Postoperative Complications/epidemiology Randomized Controlled Trials as Topic Urinary Bladder Neoplasms/*surgery Bladder cancer Meta-analysis Minimally invasive Open radical cystectomy Randomized controlled trials

*Biomarkers Tumor Carcinoma Transitional Cell/*genetics/mortality/pathology *DNA Methylation Humans Neoplasm Invasiveness Prognosis Risk Assessment Survival Rate Urinary Bladder Neoplasms/*genetics/mortality/pathology Biomarkers Dna High-risk non–muscle-invasive bladder cancer Methylation Prognostic markers Systematic review molecular markers

Css Os Pfs neoadjuvant chemotherapy outcome primary MIBC secondary MIBC

肌层浸润性膀胱癌 根治性膀胱切除术 保留膀胱 放化疗 Meta分析

经尿道膀胱肿瘤绿激光选择性汽化术 经尿道膀胱肿瘤电切术 非肌层浸润性膀胱癌 Meta分析 随机对照试验